Cargando…
Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function
BACKGROUND: Inhibition of the nuclear factor kappa beta (NF-κβ) pathway has been proposed as a therapeutic target due to its key role in the expression of pro-inflammatory genes, including pro-inflammatory cytokines, chemokines, and adhesion molecules. Caffeic acid phenethyl ester (CAPE) is a natura...
Autores principales: | Khan, Mohammed N., Lane, Majella E., McCarron, Paul A., Tambuwala, Murtaza M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859149/ https://www.ncbi.nlm.nih.gov/pubmed/28528363 http://dx.doi.org/10.1007/s10787-017-0364-x |
Ejemplares similares
-
Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis
por: Tambuwala, Murtaza M., et al.
Publicado: (2018) -
Caffeic Acid Phenethyl Ester and Therapeutic Potentials
por: Murtaza, Ghulam, et al.
Publicado: (2014) -
The Pluripotent Activities of Caffeic Acid Phenethyl Ester
por: Olgierd, Batoryna, et al.
Publicado: (2021) -
Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
por: Dai, Guoliang, et al.
Publicado: (2020) -
Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer
por: Murtaza, Ghulam, et al.
Publicado: (2014)